New online seminar: Med Tech market access for non-market access professionals

16

Jun 2020

Market access was and remains incredibly important for the commercial success of medical technologies.

The complexity of market access is also explained by the overlap of different complex areas, including regulatory, clinical epidemiology, health economics, biomedical statistics and health policy. The field of market access became very hard to understand for people from other areas, including marketing, business, clinical and regulatory affairs.

MTRC released a novel product, which was often requested by our clients from marketing, market intelligence, clinical affairs and other non-market access departments.

This seminar is designed by the industry leader in education in European market access to support Med Tech professionals outside the narrow circle of market access specialists. This seminar is designed specifically for non-market access professionals, who want to understand the area of market access better, but do not need to become a topical expert on market access. The seminar consists of four main blocks: value claims, development of clinical evidence, development of economic evidence, and market access.

The seminar is dedicated specifically to medical technologies.

You will learn all key concepts in claims management, clinical evidence, health economics and market access and will be able to better understand the goals of market access activities, instruments used, key drivers and barriers.

The seminar is available in the form of a presentation in Acrobat PDF (89 slides) and a pre-recorded webinar (2.5-hour long).

Learn more and access the seminar here

The latest related news

22

Nov 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

Read more

23

Sep 2021

In September 2021, MTRC received a certificate of conformity of the internal processes with the ISO 9001:2015 (quality management systems) standard. The certificate was issued by the United Kingdom Accreditation Service, UKAS. This confirms the commitment of the MTRC team to the provision of high-quality reimbursement services in Europe.

Read more

03

Aug 2021

A syndicated report (135 pages) reviews details of innovation funding and coverage with evidence development schemes in Europe, including Austria, Belgium, England, France, Germany, the Netherlands, and Switzerland. For each scheme, information about objective, inclusion criteria, applicant, stakeholders involved, clinical and economic evidence requirements, and statistics (including at least 2019-2020 data; but for most schemes – statistics for multiple years) is included.

Read more

12

Jul 2021

MTRC released an update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (Belgium, France, Germany, the Netherlands, and Switzerland). The updated report covers 3-year period of 2018-2020. Broader coverage gives a better understanding of the activity of the reimbursement organizations.

Read more

17

May 2021

In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services

Read more